Members
WAVA taps into the full spectrum of its members’ strengths and experience, which span the research and development process from discovery through early clinical development. WAVA’s members have decades of expertise in infectious disease, public health sciences, bioengineering formulation technology, global health delivery, and healthcare policy experience. There is a history of cooperative work among the founding member institutions:
|
|
|
|
|
|
|
|
|
|
WAVA seeks to expand its network of collaborators, drawing from the expertise of academic institutions, private research organizations, non-profits, commercial partners, and governmental institutions. WAVA’s vision is to become a leader in advancing effectual, rapid, cost-effective vaccine development and deployment. This is expected to occur not only by permitting member organizations to leverage each other’s expertise and facilities, but also through mutually beneficial intellectual property policies.
 |
WAVA currently receives funding from the Life Sciences Discovery Fund |
